Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 620 is a human protein encoded by the ZNF620 gene. It is predicted to function as a DNA-binding transcription factor, specifically regulating the activity of RNA polymerase II at sequence-specific transcription regulatory regions[1][2][5][6][7]. ZNF620 is believed to play a role in the regulation of gene expression within the nucleus, though its precise biological roles remain incompletely characterized[1][2][7]. Genetic associations have linked alterations in ZNF620 with myoclonic-atonic epilepsy and Pitt-Hopkins syndrome, suggesting possible involvement in neurodevelopmental processes[1]. No documented drugs are known to target ZNF620, and it is not currently considered a direct therapeutic target[1][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 620 (ZNF620).